Accutest Research Laboratories (I) Pvt. Ltd. is a global independent and internationally accredited Contract Research Organisation (CRO) boasting over 20 years of experience and 700+ employees. As the market leader among independent CROs, Accutest specializes in providing end-to-end services for global bio-pharmaceutical, biotech, medical device, nutraceutical, and FMCG companies. Their services span across three verticals, including Bio-availability and Bio-equivalence studies (BA/BE), Clinical Development Services (CDS), and Biologics Services. The company has a strong regulatory track record, with several accreditations and approvals from global regulatory agencies. They have successfully cleared inspections from prominent regulatory bodies such as USFDA, WHO, DCGI, and EMA multiple times. Founded in 1998 and headquartered in India, Accutest's dedication to maintaining the highest quality standards and quick turnaround times has positioned them as a reputable and reliable partner for companies operating in the biotechnology and health care industries. With a track record of successful regulatory clearances and a comprehensive service offering, Accutest presents a compelling proposition for potential investors seeking to capitalize on the growing demand for CRO services in the global healthcare market.
There is no investment information
No recent news or press coverage available for Accutest Research Laboratories (I) Pvt. Ltd..